GGrantIndex
Sort

23,748 grants matching melanoma

Biomarkers to Guide Treatment and Improve Survival in Oral/Oropharyngeal Cancer

$340,706
Thomas E. Carey · University Of Michigan At Ann Arbor · R01 · FY2012 · DE

IFN ALPHA-INDUCED DEPRESSION

$340,705
Emory University · R01 · FY2001 · MH

(PQ5) Role of Mitochondrial Division in Cancer Biology

$340,672
Jerry Edward Chipuk · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · CA

Tumor Assessment Core

$340,584
Stan Krajewski · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2009 · CA

Regulation of cell homeostasis by fbx4

$340,558
J. Alan Diehl · University Of Pennsylvania · R01 · FY2013 · CA

Laser Speckle Imaging Chip for Telehealth Applications

$340,427
Abhishek Rege · Vasoptic Medical, Inc. · R43 · FY2015 · AG

Increasing Effects of Interferons for Melanoma

$340,425
Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2004 · CA

Increasing Effects of Interferons for Melanoma

$340,425
Cleveland Clinic Lerner Col/Med-Cwru · R01 · FY2005 · CA

Optimization of Autophagy Inhibition as a Clinical Target for Brain Tumors

$340,395
Jean Marie Mulcahy Levy · University Of Colorado Denver · R01 · FY2023 · NS

Project 3: Notch signaling in oHSV therapy for GBM

$340,395
Balveen Kaur · Brigham And Women'S Hospital · P01 · FY2018 · CA

Enhancing CAR-T cell activity against solid tumors by vaccine boosting through the chimeric receptor

$340,336
Darrell J Irvine · Massachusetts Institute Of Technology · R01 · FY2021 · CA

Regulation and Role of miR-183-96-182 in Melanocyte Differentiation and Melanoma

$340,325
Eva Hernando · New York University School Of Medicine · R01 · FY2014 · CA

Regulatory T cells in B cell lymphoma

$340,300
Hyam Isaac Levitsky · Johns Hopkins University · R01 · FY2010 · CA

Regulatory T cells in B cell lymphoma

$340,300
Hyam Isaac Levitsky · Johns Hopkins University · R01 · FY2009 · CA

Regulatory T cells in B cell lymphoma

$340,300
Hyam Isaac Levitsky · Johns Hopkins University · R01 · FY2008 · CA

Identifying and targeting evolutionary trajectories in cancer

$340,243
Michael Hemann · Massachusetts Institute Of Technology · R01 · FY2019 · CA

Targeted Screen for Novel Chemical Modulators of Wnt/Beta-Cat Signaling Pathway.

$340,155
Brian D Dynlacht · New York University School Of Medicine · R01 · FY2014 · CA

Cancer Bioinformatics Services

$340,122
Michael John Becich · University Of Pittsburgh At Pittsburgh · P30 · FY2017 · CA

Cancer Bioinformatics Services

$340,122
Uma R. Chandran · University Of Pittsburgh At Pittsburgh · P30 · FY2019 · CA

HLA CLASS I PEPTIDE COMPLEX ADNORMALITIES IN MELANOMA

$340,099
Roswell Park Cancer Institute Corp · R01 · FY2002 · CA

Role of Sirt2 in T Cell Metabolism

$340,095
Sungjune Kim · Mayo Clinic Jacksonville · R37 · FY2024 · CA

Cellular Mechanisms of Therapy Resistance in Melanoma

$340,035
Meenhard Herlyn · Wistar Institute · P01 · FY2013 · CA

Systemic auto-immunization against cancer using modified radiofrequency ablation

$339,975
Svetomir Nenad Markovic · Mayo Clinic Rochester · R21 · FY2009 · CA

Systemic auto-immunization against cancer using modified radiofrequency ablation

$339,975
Svetomir Nenad Markovic · Mayo Clinic Rochester · R21 · FY2008 · CA

Core B Proteomics & Biostatistics

$339,944
Lee M Graves · Univ Of North Carolina Chapel Hill · P01 · FY2020 · CA